Attached files
| file | filename |
|---|---|
| EX-10.9 - EX-10.9 - Paratek Pharmaceuticals, Inc. | prtk-ex109_74.htm |
| EX-10.14 - EX-10.14 - Paratek Pharmaceuticals, Inc. | prtk-ex1014_457.htm |
| EX-21.1 - EX-21.1 - Paratek Pharmaceuticals, Inc. | prtk-ex211_13.htm |
| EX-31.1 - EX-31.1 - Paratek Pharmaceuticals, Inc. | prtk-ex311_9.htm |
| EX-32.1 - EX-32.1 - Paratek Pharmaceuticals, Inc. | prtk-ex321_8.htm |
| EX-32.2 - EX-32.2 - Paratek Pharmaceuticals, Inc. | prtk-ex322_10.htm |
| EX-31.2 - EX-31.2 - Paratek Pharmaceuticals, Inc. | prtk-ex312_6.htm |
| EX-10.50 - EX-10.50 - Paratek Pharmaceuticals, Inc. | prtk-ex1050_415.htm |
| 10-K - 10-K - Paratek Pharmaceuticals, Inc. | prtk-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statement (Form S-3 No. 333-238150) of Paratek Pharmaceuticals, Inc., |
|
|
(2) |
Registration Statement (Form S-8 No. 333-135506) pertaining to the Novacea, Inc. 2006 Incentive Award Plan, |
|
|
(3) |
Registration Statement (Form S-8 No. 333-150869) pertaining to the Novacea, Inc. 2006 Incentive Award Plan, |
|
|
(4) |
Registration Statements (Form S-8 Nos. 333-157927, 333-164468, 333-172041, 333-180517, 333-187254 and 333-194624) pertaining to the 2006 Incentive Award Plan of Transcept Pharmaceuticals, Inc., |
|
|
(5) |
Registration Statement (Form S-8 No. 333-160222) pertaining to the 2009 Employee Stock Purchase Plan of Transcept Pharmaceuticals, Inc., |
|
|
(6) |
Registration Statement (Form S-8 No. 333-201204) pertaining to the Paratek Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended, |
|
|
(7) |
Registration Statement (Form S-8 No. 333-205482) pertaining to the Paratek Pharmaceuticals, Inc. 2006 Incentive Award Plan, as amended and restated, the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, and the Paratek Pharmaceuticals, Inc. 2015 Inducement Plan, |
|
|
(8) |
Registration Statements (Form S-8 Nos. 333-210053, 333-217660, 333-224781, 333-230097, and 333-237084) pertaining to the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, |
|
|
(9) |
Registration Statements (Form S-8 Nos. 333-218847 and 333-228218) pertaining to the Paratek Pharmaceuticals, Inc. 2017 Inducement Plan, as amended, and |
|
|
(10) |
Registration Statement (Form S-8 No. 333-226507) pertaining to the Paratek Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan; |
of our report dated March 29, 2021, with respect to the consolidated financial statements of Paratek Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Paratek Pharmaceuticals, Inc. for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 29, 2021